CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		12 Months Ended
		Jan. 29, 2022	Jan. 30, 2021	Feb. 01, 2020
Income Statement [Abstract]
Net sales		$ 5,807,149	$ 4,920,202	$ 4,434,514
Cost of sales		3,380,539	2,813,464	2,527,995
Gross profit		2,426,610	2,106,738	1,906,519
Selling, general and administrative expenses		2,160,539	1,912,314	1,776,919
Indefinite-lived intangible impairment				19,000
Operating income		266,071	194,424	110,600
Interest income		(62)	(653)	(335)
Interest expense		77,397	219,083	253,018
Loss on extinguishment and modification of debt		20,838	17,549
Other non-operating income		(34,497)
Income (loss) before income taxes and income from equity method investees		202,395	(41,555)	(142,083)
Income tax expense (benefit)		53,473	(3,337)	(35,658)
Income from equity method investees		(10,883)	(6,482)	(2,441)
Net income (loss)		159,805	(31,736)	(103,984)
Net loss attributable to noncontrolling interest		(4,612)	(5,253)	(8,111)
Net income (loss) attributable to Class A and B-1 common stockholders		$ 164,417	$ (26,483)	$ (95,873)
Net income (loss) per Class A and B-1 common share (1):
Basic	[1]	$ 0.62	$ (0.13)	$ (0.46)
Diluted	[1]	$ 0.62	$ (0.13)	$ (0.46)
Weighted average shares used in computing net income (loss) per Class A and B-1 common share (1):
Basic	[1]	264,261	210,683	208,933
Diluted	[1]	265,338	210,683	208,933

[1] Amounts for periods prior to the Company’s conversion to a Delaware corporation have been retrospectively adjusted to give effect to the organizational transactions described in Note 1. See Note 13 for further discussion.